S
Standard BioTools Inc. (LAB)
NMS – Real Time Price. Currency in USD
0.73
-0.01 (-0.80%)
At close: Jun 26, 2026, 4:00 PM EDT
0.79
+0.06 (7.60%)
After-hours: Jun 26, 2026, 7:14 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
0.73
-0.01 (-0.80%)
At close: Jun 26, 2026, 4:00 PM EDT
0.79
+0.06 (7.60%)
After-hours: Jun 26, 2026, 7:14 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $265.8M significantly exceed its total debt $29.5M, ensuring strong financial flexibility
Total current assets $521.5M exceed Total current liabilities $42.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (1.1), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$47.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 12.36 | 3.40 | 10 | |
| Quick ratio | 11.92 | 2.52 | 10 | |
| Debt to Equity | 0.05 | 1.11 | 9.0 | |
| Debt to Assets | 0.05 | 1.58 | 9.0 | |
| Interest coverage | N/A | 4.33 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 98M | 106M | 91M | 85M | 86M |
| Gross Profit | 37M | 50M | 45M | 43M | 42M |
| Operating Income | -113M | -63M | -87M | -93M | -79M |
| Net Income | -190M | -75M | -139M | -75M | -94M |
| EBITDA | -98M | -48M | -82M | -86M | -72M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -4.4 | 74.5 | 5.5 |
| Next quarter | -5.81 | 92.33 | 5.5 |
| Current year | -3.34 | 78 | 5.5 |
| Next year | 1.95 | -162.58 | 2.0 |
| Weighted average score | 4.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -11.12 | -334.5 | -199.99 | -2731.14 | 1.0 |
| Y/Y | 4.57 | -73.7 | 42.86 | -33.47 | 4.0 |
| 3y average | -4.01 | 6.93 | 59.05 | -44.36 | 4.3 |
| 5y average | -8.49 | -42.36 | -7.95 | -59.87 | 1.0 |
| Weighted average score | 2.6 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |